Skip to main content

Table 1 Baseline characteristics, morbidities, complications, outcomes of respiratory syncytial virus (RSV) and influenza infection cases, 2013-2015

From: Risk of mortality associated with respiratory syncytial virus and influenza infection in adults

Variables

Influenza A or B (N = 312)

RSV (N = 87)

P value

Male, n (%)

153 (49.0)

47 (54.0)

0.41

Age (years) mean (SD)

62.6 (17.1)

70.0 (12.2)

< 0.01

Resident of long-term care facilities, n (%)

6 (1.9)

9 (10.3)

< 0.01

Malignancy, n (%)

32 (10.3)

12 (13.8)

0.35

Congestive heart failure, n (%)

23 (7.4)

8 (9.2)

0.57

Cerebrovascular accident, n (%)

39 (12.5)

11 (12.6)

0.97

Chronic kidney disease, n (%)

38 (12.2)

16 (18.4)

0.13

Diabetes, n (%)

80 (25.6)

24 (27.6)

0.71

Liver disease, n (%)

25 (8.0)

7 (8.0)

0.99

Chronic obstructive pulmonary disease, n (%)

15 (4.8)

11 (12.6)

< 0.01

Asthma, n (%)

20 (6.4)

3 (3.4)

0.29

Body temperature > 37.5 °C, n (%)

110 (35.3)

17 (19.5)

< 0.01

Pneumonia, n (%)

78 (25.0)

34 (39.1)

< 0.01

Respiratory bacterial superinfection, n (%)

32 (10.3)

16 (18.4)

0.05

Hypoxemia, n (%)

93 (29.8)

38 (43.7)

0.01

Mechanical ventilation, n (%)

7 (2.2)

3 (3.4)

0.52

PSI score, mean (SD)

86.5 (34.9)

107.5 (30.0)

< 0.01

Twenty-day all-cause mortality (%)

21 (6.7)

16 (18.4)

< 0.01

Sixty-day all-cause mortality (%)

38 (12.2)

22 (25.3)

< 0.01

  1. PSI pneumonia severity index, SD standard deviation
  2. PSI was calculated in all patients with or without pneumonia
  3. The body temperature was imputed for 52 patients